CJ

Claudia Jordan

Senior Director, Regulatory Operations And Compliance at Vaxcyte

Claudia Jordan, RAC, has extensive experience in regulatory operations and compliance. Claudia currently holds the role of Senior Director, Regulatory Operations and Compliance at Vaxcyte, where they provide strategic guidance and executes operational activities for regulatory submissions. Claudia applies their understanding of global regulations and guidelines to support regulatory success and compliance and implements Veeva RIM to plan and manage regulatory submissions.

Prior to their current position, Claudia held various roles at Allakos Inc, including Senior Director, Regulatory Affairs; Director, Regulatory Operations; and Associate Director, Regulatory Affairs. In these roles, they played a key role in regulatory affairs activities, overseeing regulatory submissions and operations.

Before joining Allakos Inc, Claudia worked as a Senior Manager of Regulatory Affairs at Stemcentrx, Inc. and as a Senior Manager of Regulatory Operations at Five Prime Therapeutics, Inc. In these positions, they were responsible for managing the regulatory submission process and assembling documents in eCTD format.

Claudia also gained experience as a Senior Regulatory Associate at Rigel and held a regulatory role at Hana Biosciences.

Overall, Claudia Jordan has a strong background in regulatory operations and compliance, with a focus on strategic guidance, operational activities, and regulatory submissions.

Claudia Jordan, RAC has a Bachelor's and Master's degree in Technical Writing and Instructional Technologies from San Francisco State University, which they obtained between 1998 and 2009. Prior to that, they completed their Associate of Arts degree in Liberal Studies at the College of San Mateo from 1991 to 1997. In 2011, Claudia obtained the RAC-US certification from the Regulatory Affairs Certification Program.

Links

Previous companies

Allakos logo
Rigel Pharmaceuticals logo

Timeline

  • Senior Director, Regulatory Operations And Compliance

    September, 2022 - present

View in org chart